Research and Markets: Global Syringes and Needles Pipeline Review 2015

Friday, July 31, 2015

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of the "Syringes and Needles - Pipeline Review, 2015" report to their offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Syringes and Needles pipeline products.


- Extensive coverage of the Syringes and Needles under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Syringes and Needles and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Products under Development

4 Syringes and Needles - Pipeline Products under Development by Companies

5 Syringes and Needles Companies and Product Overview

6 Syringes and Needles- Recent Developments

7 Appendix

Companies Mentioned

  • Children's Hospital Boston
  • Cornell University
  • Globe Medical Tech, Inc.
  • MedPro Safety Products, Inc.
  • Micropoint Technologies Pte Ltd
  • Olberon Medical Innovation SAS
  • Protectus Medical Devices, Inc.
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Syrindicare, Inc
  • Telezon Ltd
  • Unilife Corporation
  • Universitat Politecnica de Catalunya
  • University of South Florida

For more information visit